Specify Company / Ticker to Get the Summary
Dividend History NVCR
Dividend Analytics NVCR
Max Ratio
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Novocure Ltd
NVCRNovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally. The company's TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland. Address: Neuhofstrasse 21, Baar, Switzerland, 6340
Analytics
WallStreet Target Price
32.57 USDP/E Ratio
–Dividend Yield
–Financials NVCR
Results | 2019 | Dynamics |